Kenvue, Inc.: Hold Rating Amid Legal Uncertainties and Market Volatility
I'm PortAI, I can summarize articles.
Citi analyst Filippo Falorni maintains a Hold rating on Kenvue, Inc. with a price target of $18.00, citing legal uncertainties from the MDL case on acetaminophen affecting stock performance. Recent court hearings favoring plaintiffs led to a drop in KVUE's stock price. Barclays also maintains a Hold rating with the same price target, reflecting cautious investor sentiment amid ongoing legal proceedings.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments